chr3-191329004-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_198152.5(UTS2B):c.-664-295C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.449 in 152,236 control chromosomes in the GnomAD database, including 18,686 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.45 ( 18678 hom., cov: 33)
Exomes 𝑓: 0.34 ( 8 hom. )
Consequence
UTS2B
NM_198152.5 intron
NM_198152.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.952
Genes affected
UTS2B (HGNC:30894): (urotensin 2B) Predicted to enable G protein-coupled receptor binding activity. Predicted to be involved in regulation of blood pressure. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 3-191329004-G-C is Benign according to our data. Variant chr3-191329004-G-C is described in ClinVar as [Benign]. Clinvar id is 1273417.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.895 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UTS2B | NM_198152.5 | c.-664-295C>G | intron_variant | ENST00000340524.10 | |||
UTS2B | XM_011512631.3 | c.-461C>G | 5_prime_UTR_variant | 1/8 | |||
UTS2B | XM_017006091.2 | c.-461C>G | 5_prime_UTR_variant | 1/8 | |||
UTS2B | XM_047447899.1 | c.-260-295C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UTS2B | ENST00000340524.10 | c.-664-295C>G | intron_variant | 2 | NM_198152.5 | P1 | |||
UTS2B | ENST00000432514.5 | c.-831-295C>G | intron_variant | 5 | |||||
UTS2B | ENST00000464814.1 | n.309C>G | non_coding_transcript_exon_variant | 1/2 | 5 | ||||
UTS2B | ENST00000490825.1 | n.240-32C>G | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.449 AC: 68233AN: 152024Hom.: 18653 Cov.: 33
GnomAD3 genomes
AF:
AC:
68233
AN:
152024
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.340 AC: 32AN: 94Hom.: 8 Cov.: 0 AF XY: 0.348 AC XY: 23AN XY: 66
GnomAD4 exome
AF:
AC:
32
AN:
94
Hom.:
Cov.:
0
AF XY:
AC XY:
23
AN XY:
66
Gnomad4 AFR exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.449 AC: 68305AN: 152142Hom.: 18678 Cov.: 33 AF XY: 0.456 AC XY: 33909AN XY: 74386
GnomAD4 genome
AF:
AC:
68305
AN:
152142
Hom.:
Cov.:
33
AF XY:
AC XY:
33909
AN XY:
74386
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2530
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at